Apmonia Therapeutics logo

Apmonia Therapeutics Employee Directory

Biotechnology ResearchGrand Est, France11-50 Employees

Apmonia Therapeutics is a clinical-stage biotechnology company developing peptide-based therapies aimed at modulating the tumor microenvironment in solid cancers. Its work targets the protective ecosystem surrounding tumors that supports growth, immune escape, and treatment resistance. The lead candidate, TAX2, targets the TSP-1/CD47 signaling axis and is advancing to Phase 1/2a in advanced solid tumors after favorable preclinical data and a European regulatory clearance to initiate clinical development.

The company is based in Reims, Grand Est, France. In August 2025 it established a dedicated R&D subsidiary in Liège, Belgium, as part of expanding its European footprint, and it strengthened governance with independent board members.

Find Apmonia Therapeutics employees' phone numbers or email addresses

Apmonia Therapeutics Global Highlights

Location
Employees

Europe
19

Minus sign iconPlus sign icon
  • France
    17
  • Belgium
    2

Apmonia Therapeutics's Leadership

  • Chief Executive Officer at Apmonia Therapeutics
    A. J.
    Chief Executive Officer
  • Chief Regulatory Officer at Apmonia Therapeutics
    L. L.
    Chief Regulatory Officer
  • Chief Operating Officer at Apmonia Therapeutics
    S. G.
    Chief Operating Officer
  • Co-Founder And Board Member at Apmonia Therapeutics
    A. L.
    Co-Founder And Board Member
  • Co-Founder & Chair Of The Scientific And Clinical Advisory Board at Apmonia Therapeutics
    S. D.
    Co-Founder & Chair Of The Scientific And Clinical Advisory Board
  • Responsable Projets Drug Discovery / Project Manager - Drug Discovery at Apmonia Therapeutics
    A. P.
    Responsable Projets Drug Discovery / Project Manager - Drug Discovery
  • Senior Non-Clinical Project Manager at Apmonia Therapeutics
    A. M.
    Senior Non-Clinical Project Manager
  • Founders Representative - Board Member at Apmonia Therapeutics
    J. R.
    Founders Representative - Board Member

Apmonia Therapeutics Employee Metrics

100%
50%
0%
2026
2025
  • Entrepreneurship
  • Business
  • Program & Project Management
  • Biotechnology
  • Legal
  • Other

Contact profiles from Apmonia Therapeutics

Name
Title
Contact
Location
Last Update
  • Chief Executive Officer at Apmonia Therapeutics
    A. J.
    Chief Executive Officer
    France, Grand Est
    Jul 30, 2026
  • Chief Regulatory Officer at Apmonia Therapeutics
    L. L.
    Chief Regulatory Officer
    Belgium, Walloon Region
    Jun 05, 2026
  • Co-Founder And Board Member at Apmonia Therapeutics
    A. L.
    Co-Founder And Board Member
    France, Île-de-France
    Jul 30, 2026
  • Co-Founder & Chair Of The Scientific And Clinical Advisory Board at Apmonia Therapeutics
    S. D.
    Co-Founder & Chair Of The Scientific And Clinical Advisory Board
    France, Grand Est
    Jul 30, 2026
  • Chief Operating Officer at Apmonia Therapeutics
    S. G.
    Chief Operating Officer
    France, Île-de-France
    Apr 27, 2026
  • Responsable Projets Drug Discovery / Project Manager - Drug Discovery at Apmonia Therapeutics
    A. P.
    Responsable Projets Drug Discovery / Project Manager - Drug Discovery
    France
    Jul 30, 2026
  • Senior Non-Clinical Project Manager at Apmonia Therapeutics
    A. M.
    Senior Non-Clinical Project Manager
    France, Grand Est
    Jul 30, 2026
  • Founders Representative - Board Member at Apmonia Therapeutics
    J. R.
    Founders Representative - Board Member
    France, Île-de-France
    May 28, 2026
  • Computational Engineer at Apmonia Therapeutics
    M. G.
    Computational Engineer
    France, Occitanie
    Jun 28, 2026
  • Directeur Financiers À Temps Partagé at Apmonia Therapeutics
    A. F.
    Directeur Financiers À Temps Partagé
    France, Île-de-France
    Jul 20, 2026

Frequently Asked Questions

What is Apmonia Therapeutics known for?

Minus sign iconPlus sign icon
Apmonia Therapeutics was founded in 2019 and operates in the Biotechnology Research industry. Explore Apmonia Therapeutics's company overview page for more information.

What is Apmonia Therapeutics's most common email format?

Minus sign iconPlus sign icon
Apmonia Therapeutics employees' email format typically follows the pattern of F.Last@apmonia-therapeutics.com. Trying to find reliable and up-to-date employee contact data? Find more Apmonia Therapeutics email formats with LeadIQ.

How many employees does Apmonia Therapeutics have currently?

Minus sign iconPlus sign icon
Apmonia Therapeutics has approximately 19 employees as of July 2026. These team members are located across 1 continents, including Europe.

Who are Apmonia Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of July 2026, Apmonia Therapeutics's key employees include:

  • Chief Executive Officer: A. J.
  • Chief Regulatory Officer: L. L.
  • Chief Operating Officer: S. G.
  • Co-Founder And Board Member: A. L.
  • Co-Founder & Chair Of The Scientific And Clinical Advisory Board: S. D.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.